Submissions from 2019
Highly Convergent Total Synthesis and Assignment of Absolute Configuration of Majusculamide D, a Potent and Selective Cytotoxic Metabolite from Moorea sp, Eduardo JE Caro-Diaz, Frederick A. Valeriote, and William H. Gerwick
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors, Ezra EW Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss, Melissa L. Johnson, Christine H. Chung, Ying Chen, Bo Huang, Craig B. Davis, Francesca Toffalorio, Aron Thall, and Steven F. Powell
The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors, Shodeinde A. Coker, Herbert I. Hurwitz, Sunil Sharma, Ding Wang, Pierre Jordaan, Juan P. Zarate, and Lionel D. Lewis
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105, Alexander Drilon, Siqing Fu, Manish R. Patel, Marwan Fakih, Ding Wang, Anthony J. Olszanski, Daniel Morgensztern, Stephen V. Liu, Byoung C. Cho, Lyudmila Bazhenova, Cristina P. Rodriguez, Robert C. Doebele, Antoinette Wozniak, Karen L. Reckamp, Tara Seery, Petros Nikolinakos, Zheyi Hu, Jennifer W. Oliver, Denise Trone, Katherine McArthur, Rupal Patel, Pratik S. Multani, and Myung-Ju Ahn
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy, Michael G. Fradley, Matthew Gliksman, Josephine Emole, Federico Viganego, Isaac Rhea, Allan Welter-Frost, Merna Armanious, Dae-Hyun Lee, Christine Walko, Bijal Shah, Julio C. Chavez, Howard McLeod, Javier Pinilla-Ibarz, and Matthew B. Schabath
The KRAS, Jill Hallin, Lars D. Engstrom, Lauren Hargis, Andrew Calinisan, Ruth Aranda, David M. Briere, Niranjan Sudhakar, Vickie Bowcut, Brian R. Baer, Joshua A. Ballard, Michael R. Burkard, Jay B. Fell, John P. Fischer, Guy P. Vigers, Yaohua Xue, Sole Gatto, Julio Fernandez-Banet, Adam Pavlicek, Karen Velastagui, Richard C. Chao, Jeremy Barton, Mariaelena Pierobon, Elisa Baldelli, Emanuel F. Patricoin, Douglas P. Cassidy, Matthew A. Marx, I Rybkin, Melissa L. Johnson, Sai-Hong I. Ou, Piro Lito, Kyriakos P. Papadopoulos, Pasi A. Jänne, Peter Olson, and James G Christensen
A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment, Meredith C. Henderson, Michael Silver, Quynh Tran, Elias E. Letsios, Rao Mulpuri, David E. Reese, Ana P. Lourenco, Joshua LaBaer, Karen S. Anderson, Josie Alpers, Carrie Costantini, Nitin Rohatgi, Haythem Y. Ali, Karen Baker, Donald W. Northfelt, Karthik Ghosh, Stephen R. Grobmyer, Winnie Polen, and Judith K. Wolf
Evaluation of a Multidisciplinary Team Approach for Generating Survivorship Care Plan Treatment Summaries in Patients With Breast Cancer, Tommy Ivanics, Erica Proctor, Yalei Chen, Haythem Y. Ali, Dawn Severson, Hassan Nasser, Sonja Colbert, Laura L. Susick, Eleanor Walker, Lindsay Petersen, Jessica Bensenhaver, Randa Loutfi, S David Nathanson, and Lisa A. Newman
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry, Brittany D. Jenkins, Rachel N. Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W. Howerth, Mary Egan, Jamie Hodgson, Clayton Yates, Rick Kittles, Dhananjay A. Chitale, Haythem Y. Ali, S David Nathanson, Petros Nikolinakos, Lisa A. Newman, Michele Monteil, and Melissa B. Davis
Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors, Matthew Lei, Angela Michael, Seema Patel, and Ding Wang
The role of a low erythropoietin level for the polycythemia vera diagnosis, Oleksandra Lupak, Xiaoxia Han, Peter Xie, Sharmeen Mahmood, Hadi Mohammed, and Vijayalakshmi Donthireddy
Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer, Lucas G. Maahs, Bertha E. Sanchez, Nilesh S. Gupta, Meredith Van Harn, Evelyn R. Barrack, Prem-Veer Reddy, and Clara Hwang
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer, Daniel Morgensztern, Michal Rose, Saiama N. Waqar, John Morris, Patrick C. Ma, Thomas Reid, Christina E. Brzezniak, Karen G. Zeman, Arvinda Padmanabhan, JoAnn Hirth, Alexander I Spira, Jane B. Trepel, and Sukhmani K. Padda
Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative, Lisa A Newman, Brittany Jenkins, Yalei Chen, Joseph K Oppong, Ernest Adjei, Aisha S Jibril, Syed Hoda, Esther Cheng, Dhananjay Chitale, Jessica M Bensenhaver, Baffour Awuah, Mahteme Bekele, Engida Abebe, Ishmael Kyei, Frances Aitpillah, Michael Adinku, S. David Nathanson, LaToya Jackson, Evelyn M. Jiagge, Sofia Merajver, Lindsay Petersen, Erica Proctor, Kofi K Gyan, Rachel Martini, Rick Kittles, and Melissa B Davis
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide, Amanda B. Pilling and Clara Hwang
Castration-resistant prostate cancer: Androgen receptor inactivation induces telomere DNA damage, and damage response inhibition leads to cell death, Vidyavathi Reddy, Asm Iskander, Clara Hwang, George Divine, Mani Menon, Evelyn R. Barrack, Prem-Veer Reddy, and Sahn-Ho Kim
US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials, Jeanne M. Regnante, Nicole A. Richie, Lola Fashoyin-Aje, Michelle Vichnin, Marvella Ford, Upal B. Roy, Kenneth Turner, Laura L. Hall, Evelyn Gonzalez, Nestor Esnaola, Luther T. Clark, Homer C. Adams, Olatunji B. Alese, Keerthi Gogineni, Lorna McNeill, Daniel Petereit, Ify Sargeant, Julie Dang, Coleman Obasaju, Quita Highsmith, Simon C. Lee, Spencer C. Hoover, Erin L. Williams, and Moon S. Chen
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation, Ayman Saad, Lawrence Lamb, Tao Wang, Michael T. Hemmer, Stephen Spellman, Daniel Couriel, Amin Alousi, Joseph Pidala, Hisham Abdel-Azim, Vaibhav Agrawal, Mahmoud Aljurf, Amer M. Beitinjaneh, Vijaya R. Bhatt, David Buchbinder, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Paul Castillo, Saurabh Chhabra, Miguel A. Diaz, Shatha Farhan, Yngvar Floisand, Hadar A. Frangoul, Shahinaz M. Gadalla, James Gajewski, Robert P. Gale, Manish Gandhi, Usama Gergis, Betty K. Hamilton, Peiman Hematti, Gerhard C. Hildebrandt, Rammurti T. Kamble, Abraham S Kanate, Pooja Khandelwal, Aleksandr Lazaryn, Margaret MacMillan, David I Marks, Rodrigo Martino, Parinda A Mehta, Taiga Nishihori, Richard F Olsson, Sagar S Patel, Muna Qayed, Hemalatha G Rangarajan, Ran Reshef, Olle Ringden, Bipin N Savani, Harry C Schouten, Kirk R Schultz, Sachiko Seo, Brian C Shaffer, Melhem Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F Verdonck, Ravi Vij, Edmund K Waller, Basem William, Baldeep Wirk, Jean A Yared, Lolie C Yu, Mukta Arora, and Shahrukh Hashmi
Colorectal Cancer and Nutrition, Kannan Thanikachalam and Gazala Khan
Development of an algorithm for the systematic evaluation of patients with suspected heparin-induced thrombocytopenia, Julie Thomson, Philip Kuriakose, Long To, Michael Peters, and James Kalus
A rare case of follicular lymphoma transformed to a high-grade B-cell lymphoma in orbit, Raju K. Vaddepally, Amal Hejab, Vrushali Dabak, and Madhu P. Menon
Computationally Assisted Discovery and Assignment of a Highly Strained and PANC-1 Selective Alkaloid from Alaska's Deep Ocean, Yike Zou, Xiaojuan Wang, James Sims, Bin Wang, Pankaj Pandey, Colin L. Welsh, Robert P. Stone, Mitchell A. Avery, Robert J. Doerksen, Daneel Ferreira, Clemens Anklin, Frederick A. Valeriote, Michelle Kelly, and Mark T. Hamann
Submissions from 2018
A Lesion on the Scalp, Zaid Abdel-Rahman, Kedar Inamdar, and Haythem Y. Ali
Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis, Sharon Hensley Alford, George Divine, Chun Chao, Laurel A. Habel, Nalini Janakiraman, Yun Wang, Heather Spencer Feigelson, Delia Scholes, Doug Roblin, Mara M. Epstein, Lawrence Engel, Suzanne Havstad, Karen Wells, Marianne Ulcickas Yood, Joan Fortuny, and Christine C. Johnson
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer, Aditya Bardia, Ayca Gucalp, Noashir DaCosta, Nashat Gabrail, Michael Danso, Haythem Y. Ali, Kimberly L. Blackwell, Lisa A. Carey, Joel R. Eisner, Edwina S. Baskin-Bey, and Tiffany A. Traina
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer, Jessica L. Christenson, Jane B. Trepel, Haythem Y. Ali, Sunmin Lee, Joel R. Eisner, Edwina S. Baskin-Bey, Anthony D. Elias, and Jennifer K. Richer
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study, S de Vos, L J. Swinnen, Ding Wang, E Reid, N Fowler, J Cordero, M Dunbar, S H. Enschede, C Nolan, A M. Petrich, J A. Ross, A H. Salem, M Verdugo, S Agarwal, L Zhou, M Kozloff, L J. Nastoupil, and C R. Flowers
Unexplained pancytopenia in acute myeloid leukemia treatment, Daniel Ezekwudo, Oleksandra Lupak, Raju Vaddepally, Bolanle Gbadamosi, and Philip Kuriakose
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer, R S. Finn, D H. Ahn, M M. Javle, B R. Tan, C D. Weekes, J C. Bendell, A Patnaik, Gazala Khan, D Laheru, R Chavira, J Christy-Bittel, E Barrett, M B. Sawyer, and Tanios S. Bekaii-Saab
A Retrospective Study Analyzing the Appropriateness of Initial Treatment of, Aaron Fisher, Pradeep Khanal, Ewa Gniado, Leila Khaddour, Molly Orosey, Ismail Hader, Siddhartha Yadav, and Alexandra Halalau
Nab-paclitaxel-based therapy in underserved patient populations: The aboundPs2 study in patients with nsclc and a performance status of 2, Ajeet Gajra, Nagla A. Karim, Deborah A. Mulford, Liza C. Villaruz, Marc R. Matrana, Haythem Y. Ali, Edgardo S. Santos, Tymara Berry, Teng J. Ong, Alexandra Sanford, Katayoun Amiri, and David R. Spigel
Management of haemophilia carriers around the time of their delivery: Phenotypic variation requiring customization of management, M R. Girgis, L Gusba, and Philip Kuriakose
Genitourinary Pathology Reporting Parameters Most Relevant to the Medical Oncologist, Clara Hwang
Enrichment and mutation detection of circulating tumor cells from blood samples, Ruqin Kou, Jian Zhao, Priya Gogoi, Shannon Carskadon, Will Chow, Clara Hwang, Nallasivam Palanisamy, Conrad Leung, and Yixin Wang
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants, Anita J. Kumar, Soyoung Kim, Michael T. Hemmer, Mukta Arora, Stephen R. Spellman, Joseph A. Pidala, Daniel R. Couriel, Amin M. Alousi, Mahmoud D. Aljurf, Jean-Yves Cahn, Mitchell S. Cairo, Corey S. Cutler, Shatha Farhan, Usama Gergis, Gregory A. Hale, Shahrukh K. Hashmi, Yoshihiro Inamoto, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Margaret L. MacMillan, David I. Marks, Hideki Nakasone, Maxim Norkin, Muna Qayed, Olle Ringden, Harry C. Schouten, Kirk R. Schultz, Melhem M. Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F. Verdonck, Robert P. Gale, Betty K Hamilton, Navneet S Majhail, and Alison W Loren
The potential of achiral sponge-derived and synthetic bromoindoles as selective cytotoxins against PANC-1 tumor cells, Nicholas Lorig-Roach, Frances Hamkins-Indik, Tyler A. Johnson, Karen Tenney, Frederick A. Valeriote, and Phillip Crews
SAPHO Syndrome Masquerading as Metastatic Breast Cancer, Devin Malik, Richa Handa, Andrew Petraszko, and Sheela Tejwani
Normolipemic Xanthomas in a Patient with Underlying Plasma Cell Dyscrasia, Devin Malik, Sukhpreet Singh, and Akshay Amaraneni
Breast cancer metastasis through the lympho-vascular system, S. David Nathanson, David Krag, Henry M. Kuerer, Lisa A. Newman, Markus Brown, Dontscho Kerjaschki, Ethel R. Pereira, and Timothy P. Padera
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy, Ko-Un Park, Yalei Chen, Dhananjay A. Chitale, Sarah Choi, Haythem Y. Ali, S David Nathanson, Jessica Bensenhaver, Erica Proctor, Lindsay Petersen, Randa Loutfi, Alyson Simonds, Marcia Kuklinski, Thomas Doyle, Vrushali Dabak, Kim Cole, Melissa B. Davis, and Lisa A. Newman
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial, Manish R. Patel, John Ellerton, Jeffrey R. Infante, Manish Agrawal, Michael Gordon, Raid Aljumaily, Carolyn D. Britten, Luc Dirix, Keun-Wook Lee, Mathew Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Arnold B. Gelb, Junyuan Xiong, Galit Rosen, James L. Gulley, and Andrea B. Apolo
ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer, Amanda B. Pilling, Jihye Kim, Adriana Estrada-Bernal, Qiong Zhou, Anh T. Le, Katherine R. Singleton, Lynn E. Heasley, Aik C. Tan, James DeGregori, and Robert C. Doebele
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours, Eric Raymond, Matthew H. Kulke, Shukui Qin, Xianjun Yu, Michael Schenker, Antonio Cubillo, Wenhui Lou, Jiri Tomasek, Espen Thiis-Evensen, Jian-Ming Xu, Adina E. Croitoru, Mustafa Khasraw, Eva Sedlackova, Ivan Borbath, Paul Ruff, Paul E. Oberstein, Tetsuhide Ito, Liqun Jia, Pascal Hammel, Lin Shen, Shailesh V. Shrikhande, Yali Shen, Jozef Sufliarsky, Gazala Khan, Chigusa Morizane, Salvatore Galdy, Reza Khosravan, Kathrine C. Fernandez, Brad Rosbrook, and Nicola Fazio
A cross-sectional analysis of cardiovascular disease in the hemophilia population, Suman L. Sood, Dunlei Cheng, Margaret Ragni, Craig M. Kessler, Doris Quon, Amy D. Shapiro, Nigel S. Key, Marilyn J. Manco-Johnson, Adam Cuker, Christine Kempton, Tzu-Fei Wang, M E. Eyster, Philip Kuriakose, Annette von Drygalski, Joan C. Gill, Allison Wheeler, Peter Kouides, Miguel A. Escobar, Cindy Leissinger, Sarah Galdzicka, Marshall Corson, Crystal Watson, and Barbara A. Konkle
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer, M L. Telli, D G. Stover, S Loi, S Aparicio, L A. Carey, S M. Domchek, Lisa A. Newman, G W. Sledge, and E P. Winer
Computationally Assisted Assignment of the Kadsuraols, a Class of Chemopreventive Agents for the Control of Liver Cancer, Xiaojuan Wang, Jiabao Liu, Pankaj Pandey, Frank R. Fronczek, Robert J. Doerksen, Jiabao Chen, Xinzhu Qi, Peicheng Zhang, Daneel Ferreira, Frederick A. Valeriote, Hua Sun, Shuai Li, and Mark T. Hamann
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial, D A. Yardley, R Coleman, P Conte, J Cortes, A Brufsky, M Shtivelband, R Young, C Bengala, Haythem Y. Ali, J Eakel, A Schneeweiss, L de la Cruz-Merino, S Wilks, J O'Shaughnessy, S Glück, H Li, J Miller, D Barton, and N Harbeck
Submissions from 2017
Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study, Yaser Alkhatib, Zaid Abdel-Rahman, and Philip Kuriakose
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study, Andrea B. Apolo, Jeffrey R. Infante, Ani Balmanoukian, Manish R. Patel, Ding Wang, Karen Kelly, Anthony E. Mega, Carolyn D. Britten, Alain Ravaud, Alain C. Mita, Howard Safran, Thomas E. Stinchcombe, Marko Srdanov, Arnold B. Gelb, Michael Schlichting, Kevin Chin, and James L. Gulley
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor, Johanna C. Bendell, Milind Javle, Tanios S. Bekaii-Saab, Richard S. Finn, Zev A. Wainberg, Daniel A. Laheru, Colin D. Weekes, Benjamin R. Tan, Gazala Khan, Mark M. Zalupski, Jeffrey R. Infante, Suzanne Jones, Kyriakos P. Papadopoulos, Anthony W. Tolcher, Renae E. Chavira, Janna L. Christy-Bittel, Emma Barrett, and Amita Patnaik
Role of Kindness in Cancer Care, Leonard L. Berry, Tracey S. Danaher, Robert A. Chapman, and Rana Awdish
Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists, Susan Eggly, Lauren M. Hamel, Tanina S. Foster, Terrance L. Albrecht, Robert Chapman, Felicity WK Harper, Hayley Thompson, Jennifer J. Griggs, Richard Gonzalez, Lisa Berry-Bobovski, Rifky Tkatch, Michael Simon, Anthony Shields, Shirish Gadgeel, Randa Loutfi, Haythem Y. Ali, Ira Wollner, and Louis A. Penner
Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy, Shatha Farhan, Michael Bazydlo, Klodiana Neme, Nancy Mikulandric, Edward Peres, and Nalini Janakiraman
TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer, Kurt W. Fisher, Shaobo Zhang, Mingsheng Wang, Rodolfo Montironi, Lisha Wang, Lee A. Baldrige, Jonas Y. Wang, Gregory T. MacLennan, Sean R. Williamson, Antonio Lopez-Beltran, and Liang Cheng
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G. Berdeja, Yasmin Abaza, Elias Jabbour, James Essell, Roger M. Lyons, Farhad Ravandi, Michael Maris, Brian Heller, Amy E. DeZern, Sunil Babu, David Wright, Bertrand Anz, Ralph Boccia, Rami S. Komrokji, Philip Kuriakose, James Reeves, Mikkael A. Sekeres, Hagop M. Kantarjian, Richard Ghalie, and Gail J. Roboz
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial, James L. Gulley, Arun Rajan, David R. Spigel, Nicholas Iannotti, Jason Chandler, Deborah JL Wong, Joseph Leach, W J. Edenfield, Ding Wang, Hans J. Grote, Anja von Heydebreck, Kevin Chin, Jean-Marie Cuillerot, and Karen Kelly
Do Patients and Oncologists Discuss the Cost of Cancer Treatment? An Observational Study of Clinical Interactions Between African American Patients and Their Oncologists, Lauren M. Hamel, Louis A. Penner, Susan Eggly, Robert Chapman, Justin F. Klamerus, Michael S. Simon, Sarah CE Stanton, and Terrance L. Albrecht
Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry, N L. Henry, Thomas M. Braun, Haythem Y. Ali, Khan Munir, Samuel M. Silver, David H. Gorski, Tara M. Breslin, and Jennifer J. Griggs
Another Look at Pyrroloiminoquinone Alkaloids-Perspectives on Their Therapeutic Potential from Known Structures and Semisynthetic Analogues, Sheng Lin, Erin P. McCauley, Nicholas Lorig-Roach, Karen Tenney, Cassandra N. Naphen, Ai-Mei Yang, Tyler A. Johnson, Thalia Hernadez, Ramandeep Rattan, Frederick A. Valeriote, and Phillip Crews
Renal Complications of Hematopoietic Stem Cell Transplantation: Report of a Case and Review of the Literature, Egbert Liquete, Sean R. Williamson, Nalini Janakiraman, and K. K. Venkat
A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years, Ana P. Lourenco, Kasey L. Benson, Meredith C. Henderson, Michael Silver, Elias Letsios, Quynh Tran, Kelly J. Gordon, Sherri Borman, Christa Corn, Rao Mulpuri, Wendy Smith, Josie Alpers, Carrie Costantini, Nitin Rohatgi, Rebecca Yang, Haythem Y. Ali, Shah Biren, Michael Morris, Fred Kass, and David E. Reese
Investigation of the Physical and Bioactive Properties of Bromo- and Iodo-Containing Sponge-Derived Compounds Possessing an Oxyphenylethanamine Core, Erin P. McCauley, Hanh Lam, Nicholas Lorig-Roach, Justin Luu, Cameron Lloyd, Karen Tenney, Halina Pietraszkiewicz, Cristina Diaz, Frederick A. Valeriote, Victoria Auerbuch, and Phillip Crews
Clues to the Blues: Predictors of Self-Reported Mental and Emotional Health Among Older African American Men, Jamie A. Mitchell, Daphne C. Watkins, Deirdre Shires, Robert A. Chapman, and Janice Burnett
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States, Lori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu, Kehinde Adekola, Mahmoud Aljurf, Karen K. Ballen, Ashish Bajel, Frederic Baron, Minoo Battiwalla, Amer Beitinjaneh, Jean-Yves Cahn, Mathew Carabasi, Yi-Bin Chen, Saurabh Chhabra, Stefan Ciurea, Edward Copelan, Anita D'Souza, John Edwards, James Foran, Cesar O. Freytes, Henry C. Fung, Robert P. Gale, Sergio Giralt, Shahrukh K. Hashmi, Gerhard C. Hildebrandt, Vincent Ho, Ann Jakubowski, Hillard Lazarus, Marlise R. Luskin, Rodrigo Martino, Richard Maziarz, Philip McCarthy, Taiga Nishihori, Rebecca Olin, Richard F Olsson, Attaphol Pawarode, Edward Peres, Andrew R Rezvani, David Rizzieri, Bipin N Savani, Harry C Schouten, Mitchell Sabloff, Matthew Seftel, Sachiko Seo, Mohamed L Sorror, Jeff Szer, Baldeep M Wirk, William A Wood, and Andrew Artz
Integrating Molecular Networking and Biological Assays To Target the Isolation of a Cytotoxic Cyclic Octapeptide, Samoamide A, from an American Samoan Marine Cyanobacterium, C B. Naman, Ramandeep Rattan, Svetlana E. Nikoulina, John Lee, Bailey W. Miller, Nathan A. Moss, Lorene Armstrong, Paul D. Boudreau, Hosana M. Debonsi, Frederick A. Valeriote, Pieter C. Dorrestein, and William H. Gerwick
Metastatic Cutaneous Melanoma of the Gallbladder, Dhruvan Patel, Shazia Sohrawardy, Yub R. Sedhai, Soney Basnyat, Anisha Daxini, Aparna Basu, Vivek R. Mehta, Aasim Mohammed, and Steven Lichtenstein
IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α Signaling, Amanda B. Pilling, Ok Hwang, Alain Boudreault, Alain Laurent, and Clara Hwang
Cytotoxic halogenated monoterpenes from Plocamium cartilagineum, Omar MM Sabry, Douglas E. Goeger, Frederick A. Valeriote, and William H. Gerwick
Using Speed of Sound Imaging to Characterize Breast Density, Mark Sak, Neb Duric, Peter Littrup, Lisa Bey-Knight, Haythem Y. Ali, Patricia Vallieres, Mark E. Sherman, and Gretchen L. Gierach
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma, M Schlumberger, R Elisei, S Müller, P Schöffski, M Brose, M Shah, L Licitra, J Krajewska, M C. Kreissl, B Niederle, E EW Cohen, L Wirth, Haythem Y. Ali, D O. Clary, Y Yaron, M Mangeshkar, D Ball, B Nelkin, and S Sherman
Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells, Vijayalakshmi Thamilselvan, Mani Menon, Gary S. Stein, Frederick A. Valeriote, and Sivagnanam Thamilselvan
Solitary Skeletal Muscle Metastasis as First Site of Recurrence of Cervical Cancer: A Case Report, Indumathy Varadarajan, Aparna Basu, Sherri Besmer, Jaganmohan Poli, Scott Richard, and Michael Styler
Submissions from 2016
Immunotherapy: A New Approach to Treating Multiple Myeloma with Daratumumab and Elotuzumab, Salma Afifi, Alexander T. Michaels, and Alexander Lesokhin
The role of tyrosine kinase inhibitor "Lapatinib" in pulmonary hypertension, Yaser Alkhatib, Derar Albashaireh, Tameem Al-Aqtash, and Rana Awdish
Lymphadenopathy in a patient with chronic myeloid leukaemia, Yaser Alkhatib and Yue Guo
Kalkipyrone B, a marine cyanobacterial γ-pyrone possessing cytotoxic and anti-fungal activities, Matthew J. Bertin, Ozlem Demirkiran, Gabriel Navarro, Nathan A. Moss, John Lee, Gregory M. Goldgof, Edgar Vigil, Elizabeth A. Winzeler, Frederick A. Valeriote, and William H. Gerwick
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors, Laura QM Chow, David C. Smith, Antoinette R. Tan, Crystal S. Denlinger, Ding Wang, Dale R. Shepard, Archana Chaudhary, Yong Lin, and Ling Gao
Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis, Gautam Edhayan, Ray A. Ohara, W A. Stinson, M A. Amin, Takeo Isozaki, Christine M. Ha, G K. Haines, Rachel Morgan, Phillip L. Campbell, Ali S. Arbab, Sean C. Friday, David A. Fox, and Jeffrey H. Ruth
Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published Literature, Shatha Farhan, Edward Peres, and Nalini Janakiraman
MiR-129-5p-mediated Beclin-1 suppression inhibits endothelial cell autophagy in atherosclerosis, Zhaohua Geng, Fei Xu, and Yiguan Zhang
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer, Miriana Hijaz, Soumen Das, Ismail Mert, Ankur Gupta, Zaid Al-Wahab, Calvin Tebbe, Sajad Dar, Jasdeep Chhina, Shailendra Giri, Adnan R. Munkarah, Sudipta Seal, and Ramandeep Rattan
The Effect of Time to Castration Resistance on Outcomes With Abiraterone and Enzalutamide in Metastatic Prostate Cancer, Jonathan Hung, Ashley Taylor, George W. Divine, Jason M. Hafron, and Clara Hwang
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients, Clara Hwang, Seema Sethi, Lance K. Heilbrun, Nilesh S. Gupta, Dhananjay A. Chitale, Wael A. Sakr, Mani Menon, James O. Peabody, Daryn W. Smith, Fazlul H. Sarkar, and Elisabeth I. Heath
Sailing in troubled waters': a review of the use of anticoagulation in adult cancer patients with thrombocytopenia, Rami B. Ibrahim, Michelle D. Skewes, and Philip Kuriakose
Warfarin Dosing and Time Required to Reach Therapeutic International Normalized Ratio in Patients with Hypercoagulable Conditions, Pushpinderdeep Kahlon, Shahzaib Nabi, Adeel Arshad, Absia Jabbar, and Ali Haythem
Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis, Pooja Kulkarni, Terra Cushman, Vijayalakshmi Donthireddy, and Sudhaker D. Rao
The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase, Nitin Kumar, Pablo Nakagawa, Brana Janic, Cesar A. Romero, Morel E. Worou, Sumit R. Monu, Edward L. Peterson, Jiajiu Shaw, Frederick A. Valeriote, Elimelda M. Ongeri, Jean-Marie V. Niyitegeka, Nour-Eddine Rhaleb, and Oscar A. Carretero
Predicting Incongruence between Self-reported and Documented Colorectal Cancer Screening in a Sample of African American Medicare Recipients, Mark Manning, Janice Burnett, and Robert Chapman
Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data, Ankit Modh, A I. Ghanem, C Burmeister, Nabila Rasool, and Mohamed A. Elshaikh
Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer, Dipenkumar Modi, Clara Hwang, Hirva Mamdani, Seongho Kim, Hesham Gayar, Ulka Vaishampayan, Richard Joyrich, and Elisabeth I. Heath
Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence, Adnan R. Munkarah, Ismail Mert, Jasdeep Chhina, Suhail Hamid, Laila M. Poisson, Sharon Hensley-Alford, Shailendra Giri, and Ramandeep Rattan
Predictors of Venous Thromboembolism in Patients with Glioblastoma, Shahzaib Nabi, Pushpinderdeep Kahlon, Farshid Bozorgnia, Adeel Arshad, Tom Mikkelsen, and Vijayalakshmi Donthireddy
Analyzing Relationship Between Monoclonal Gammopathy of Undetermined Significance (MGUS) with Different Types of Neuropathy: An Observational Study, Shahzaib Nabi, Pushpinderdeep Kahlon, Farshid Bozorgnia, Adeel Arshad, Akmam Saleem, and Philip Kuriakose
The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions, Louis A. Penner, John F. Dovidio, Richard Gonzalez, Terrance L. Albrecht, Robert Chapman, Tanina Foster, Felicity WK Harper, Nao Hagiwara, Lauren M. Hamel, Anthony F. Shields, Shirish Gadgeel, Michael S. Simon, Jennifer J. Griggs, and Susan Eggly
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study, Sandeep Rana, Elizabeth C. Blowers, Calvin Tebbe, Jacob I. Contreras, Prakash Radhakrishnan, Smitha Kizhake, Tian Zhou, Rajkumar N. Rajule, Jamie L. Arnst, Adnan R. Munkarah, Ramandeep Rattan, and Amarnath Natarajan
Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer, Benjamin A. Rybicki, Andrew Rundle, Oleksandr N Kryvenko, Nicoleta Mitrache, Kieu C. Do, Michelle Jankowski, Dhananjay A. Chitale, Sheri Trudeau, Steven A. Belinsky, and Deliang Tang
Progression of a hepatosplenic gamma delta T-cell leukemia/lymphoma on hyperCVAD/MTX and ara-C: literature review and our institutional treatment approach, Abhijit Saste, Javier Arias-Stella, and Philip Kuriakose
Paraneoplastic Syndrome in Splenic Marginal Zone Lymphoma: A Rare Phenomenon of Paraplegia as an Atypical Presenting Manifestation, Jessica Schering and Vijayalakshmi Donthireddy
Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis, Ann G. Schwartz, Christine M. Lusk, Angela S. Wenzlaff, Donovan Watza, Stephanie Pandolfi, Laura Mantha, Michele L. Cote, Ayman O. Soubani, Garrett Walworth, Antoinette Wozniak, Christine Neslund-Dudas, Amy A. Ardisana, Michael Flynn, Thomas Song, David L. Spizarny, P Kvale, Robert A. Chapman, and Shirish M. Gadgeel
Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors, Ding Wang, Fadi Braiteh, James J. Lee, Crystal S. Denlinger, Dale R. Shepard, Archana Chaudhary, Yong Lin, Ling Gao, Christopher Asakiewicz, Federico Nasroulah, and Patricia LoRusso
